RESUMEN
BACKGROUND: Infants with chylothorax after congenital heart disease surgery are commonly treated using modified-fat breast milk. The effect of fat removal on breast milk macronutrients remains unclear. We compared macronutrient content of breast milk with breast milk skimmed using 3 methods, including a novel device, a cream separator. METHODS: Thawed frozen breast milk samples from 30 women were defatted using refrigerated centrifuge, cream separator, and manual separation after refrigeration. We used standard assays to measure energy, protein, and fat content of breast milk samples. RESULTS: All fat removal methods yielded skimmed breast milk with substantially lower fat and energy content. Mean energy content in breast milk skimmed by centrifuge (36.7 [SD 3.6] kcal/100 mL) was similar to that from cream separator (38.8 [3.5] kcal/100 mL). Both centrifuge and cream separator methods removed almost all fat and substantially more fat than the manual fat removal method. For unprocessed milk, energy and fat content estimated by creamatocrit was similar to reference method measurements; in skimmed milk, the creamatocrit significantly overestimated fat content. Mean protein content of skimmed breast milk was similar to unprocessed breast milk (mean 1.25 [0.31] g/100 mL). CONCLUSION: Breast milk fat removal did not significantly alter protein levels. In skimmed breast milk, the overestimation of fat content using creamatocrit method suggests a need for more accurate bedside methods to assess macronutrient content. The similar macronutrient composition of breast milk skimmed by cream separator and centrifuge suggests the potential for cream separator use as a new, portable defatting method for hospitals and families.
Asunto(s)
Leche Humana , Nutrientes , Animales , Quilotórax , Femenino , Humanos , LactanteRESUMEN
Growing evidence supporting the health benefits of human milk, particularly in the preterm population, has led to rising demand for donor human milk in NICUs and pediatric hospitals. There are no previous reports describing the use of unpasteurized shared human milk (USHM) in the hospital setting, but the use of USHM solicited from community donors through social networks appears to be common. Many pediatric hospitals permit inpatients to receive breast milk that has been screened and pasteurized by a human milk banking organization and will provide pasteurized donor human milk (PDHM) only to infants who are preterm or have specific medical conditions. These policies are designed to minimize potential adverse effects from improperly handled or screened donor milk and to target patients who would experience the greatest benefit in health outcomes with donor milk use. We explore the ethical and health implications of 2 cases of medically complex infants who did not meet criteria in our tertiary care hospital for the use of PDHM from a regulated human milk bank and were incidentally found to be using USHM. These cases raise questions about how best to balance the ethical principles of beneficence, nonmaleficence, justice, and patient autonomy in the provision of PDHM, a limited resource. Health care staff should ask about USHM use to provide adequate counseling about the risks and benefits of various feeding options in the context of an infant's medical condition.
Asunto(s)
Métodos de Alimentación , Inocuidad de los Alimentos/métodos , Trastornos de la Nutrición del Lactante , Enfermedades del Recién Nacido/terapia , Leche Humana , Pasteurización , Selección de Donante/ética , Selección de Donante/organización & administración , Selección de Donante/normas , Métodos de Alimentación/efectos adversos , Métodos de Alimentación/ética , Métodos de Alimentación/normas , Femenino , Humanos , Lactante , Alimentos Infantiles/efectos adversos , Alimentos Infantiles/análisis , Alimentos Infantiles/normas , Trastornos de la Nutrición del Lactante/etiología , Trastornos de la Nutrición del Lactante/prevención & control , Recién Nacido , Enfermedades del Recién Nacido/diagnóstico , Recien Nacido Prematuro/fisiología , Bancos de Leche Humana , Evaluación de Necesidades , Pasteurización/métodos , Pasteurización/normas , Medición de Riesgo , Red SocialRESUMEN
Achieving an AIDS-free generation will require elimination of postnatal transmission of HIV-1 while maintaining the nutritional and immunologic benefits of breastfeeding for infants in developing regions. Maternal/infant antiretroviral prophylaxis can reduce postnatal HIV-1 transmission, yet toxicities and the development of drug-resistant viral strains may limit the effectiveness of this strategy. Interestingly, in the absence of antiretroviral prophylaxis, greater than 90% of infants exposed to HIV-1 via breastfeeding remain uninfected, despite daily mucosal exposure to the virus for up to 2 y. Moreover, milk of uninfected women inherently neutralizes HIV-1 and prevents virus transmission in animal models, yet the factor(s) responsible for this anti-HIV activity is not well-defined. In this report, we identify a primary HIV-1-neutralizing protein in breast milk, Tenascin-C (TNC). TNC is an extracellular matrix protein important in fetal development and wound healing, yet its antimicrobial properties have not previously been established. Purified TNC captured and neutralized multiclade chronic and transmitted/founder HIV-1 variants, and depletion of TNC abolished the HIV-1-neutralizing activity of milk. TNC bound the HIV-1 Envelope protein at a site that is induced upon engagement of its primary receptor, CD4, and is blocked by V3 loop- (19B and F39F) and chemokine coreceptor binding site-directed (17B) monoclonal antibodies. Our results demonstrate the ability of an innate mucosal host protein found in milk to neutralize HIV-1 via binding to the chemokine coreceptor site, potentially explaining why the majority of HIV-1-exposed breastfed infants are protected against mucosal HIV-1 transmission.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/transmisión , VIH-1/efectos de los fármacos , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Leche Humana/química , Tenascina/farmacología , Síndrome de Inmunodeficiencia Adquirida/prevención & control , Western Blotting , Línea Celular , Cromatografía por Intercambio Iónico , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Inmunoprecipitación , Concentración 50 Inhibidora , Espectrometría de Masas , Tenascina/metabolismo , Proteínas del Envoltorio Viral/metabolismoRESUMEN
When an infant is medically compromised or requires surgery shortly after birth, traditional breastfeeding is interrupted. In the United States, mothers of these medically complex infants often spend many hours using a breast pump to express their breast milk and store it for their baby to receive via a feeding tube or bottle until breastfeeding can be introduced. Often, additional calories, minerals, or modifications are made to mother's milk to meet the infant's needs. Many acute care pediatric facilities and neonatal intensive care units lack appropriate physical space for the preparation of fortified breast milk feedings, and the preparation of these feedings by nursing staff requires a significant investment of time. At Boston Children's Hospital, the innovative role of a mother's milk technician was created to provide preparation of breast milk utilizing standardized measurement of fortifiers by weight, prepared using an aseptic technique with standard operating procedures. The creative use of a "mobile" milk cart was implemented due to limited space allocated for formula lab and nutrition rooms. The development of this essential role has ensured optimal quality control of the storage and preparation of expressed human milk. Nursing compliance with breast milk identification procedures increases when time required for feeding preparation is minimized, preventing breast milk administration errors and reallocating valuable nursing time back to the patient.
Asunto(s)
Técnicos Medios en Salud/normas , Alimentos Fortificados/normas , Cuidado Intensivo Neonatal/normas , Leche Humana , Rol Profesional , Garantía de la Calidad de Atención de Salud/normas , Técnicos Medios en Salud/organización & administración , Actitud del Personal de Salud , Boston , Extracción de Leche Materna , Humanos , Recién Nacido , Cuidado Intensivo Neonatal/métodos , Cuidado Intensivo Neonatal/organización & administración , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Mejoramiento de la CalidadAsunto(s)
Lactancia Materna , Anomalías Congénitas , Cuidado del Lactante/métodos , Humanos , Recién NacidoRESUMEN
INTRODUCTION: Transmission of cytomegalovirus (CMV) via breast milk can lead to severe acute illness in very low-birth-weight (VLBW) preterm infants. Although the majority of CMV-seropositive women shed CMV in milk, symptomatic postnatal infection of VLBW infants occurs infrequently, suggesting that virologic or immunologic factors in milk may be associated with the risk and severity of postnatal CMV infection. METHODS: We investigated the magnitude of CMV-specific cellular and humoral immune responses in milk of 30 seropositive mothers of VLWB preterm infants and assessed their relationship to milk CMV load and symptomatic CMV transmission. RESULTS: Milk immunoglobulin G (IgG) avidity was inversely correlated to milk CMV load (r = -0.47; P = .009). However, milk CMV load and CMV-specific cellular and humoral immune responses were similar in mothers of VLBW infants with and those without symptomatic postnatal CMV infection. CONCLUSIONS: Similar immunologic parameters in milk of CMV-seropositive mothers of VLBW infants with and without symptomatic postnatal CMV infection indicate that screening milk by these parameters may not predict disease risk. However, the inverse correlation between milk CMV IgG avidity and CMV load may suggest that enhancement of maternal CMV-specific IgG responses could aid in reduction of CMV shedding into breast milk.
Asunto(s)
Infecciones por Citomegalovirus/inmunología , Infecciones por Citomegalovirus/transmisión , Citomegalovirus/inmunología , Enfermedades del Prematuro/inmunología , Recién Nacido de muy Bajo Peso/inmunología , Transmisión Vertical de Enfermedad Infecciosa , Leche Humana/inmunología , Adolescente , Adulto , Afinidad de Anticuerpos/inmunología , Lactancia Materna/efectos adversos , Citomegalovirus/aislamiento & purificación , Infecciones por Citomegalovirus/diagnóstico , Femenino , Edad Gestacional , Humanos , Inmunidad Celular , Inmunidad Humoral , Inmunoglobulina A/inmunología , Inmunoglobulina G/inmunología , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/diagnóstico , Recuento de Leucocitos , Leche Humana/virología , Carga Viral/inmunología , Adulto JovenRESUMEN
It is a widespread misconception that infants with congenital heart disease (CHD) are not able to breastfeed. The purpose of this study was to describe breastfeeding duration and outcomes among a high-risk group of infants with CHD. Mothers of 68 infants at least 6 months of age, who had experienced cardiac surgery during the neonatal period, were surveyed regarding breastfeeding and milk expression habits. Results for this sample of infants were compared to a benchmark study conducted in 1993 at the same institution that described breastfeeding outcomes for 45 infants with CHD. Improved outcomes for the 1998-2000 sample are attributed to an active lactation consultation program instituted in 1998. These findings suggest that given support and education necessary to initiate and maintain lactation, mothers can successfully breastfeed their infants with CHD for durations recommended by the Healthy People 2010 initiative.